DISC MEDICINE
Disc Medicine is led by an experienced team of scientists and industry experts, and supported by a panel of advisors with a strong track record of discovering and developing new and innovative therapies. Disc Medicine was founded by Atlas Venture and Brian MacDonald, with Novo Ventures and Access Biotechnology joining as additional investors.
DISC MEDICINE
Industry:
Biotechnology Health Care Medical
Founded:
2017-01-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.discmedicine.com
Total Employee:
11+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
140 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Analytics Google Tag Manager WordPress Google Universal Analytics Font Awesome Global Site Tag Nginx Sitelinks Search Box
Similar Organizations
Aerogen
Aerogen is a medical device and drug delivery company.
Andrew Technologies
Andrew Technologies is a medical technology company.
Apitope
Apitope is a European biotech company
Calimmune
Calimmune is a clinical-stage gene therapy company.
Faze Medicines
Faze Medicines is a biotechnology company.
Geneius
Geneius is a Biotechnology company.
Life Length
Life Length is a biotechnology company.
Neumora Therapeutics
Neumora Therapeutics operates as a clinical-stage biotechnology company.
Ocugen
Ocugen is a clinical stage biopharmaceutical company.
Robocath
Robocath is a medical robotics start-up company.
The Hemp Company
The Hemp Company is a hemp company.
Current Advisors List
Current Employees Featured
Founder
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2022-08-10 | Gemini Therapeutics | Gemini Therapeutics acquired by Disc Medicine | N/A |
Investors List
Atlas Venture
Atlas Venture investment in Venture Round - Disc Medicine
Rock Springs Capital
Rock Springs Capital investment in Venture Round - Disc Medicine
Novo Holdings
Novo Holdings investment in Venture Round - Disc Medicine
Access Biotechnology
Access Biotechnology investment in Venture Round - Disc Medicine
Arix Bioscience
Arix Bioscience investment in Venture Round - Disc Medicine
5AM Ventures
5AM Ventures investment in Venture Round - Disc Medicine
OrbiMed
OrbiMed investment in Venture Round - Disc Medicine
Janus Henderson Investors
Janus Henderson Investors investment in Venture Round - Disc Medicine
Nantahala Capital Management
Nantahala Capital Management investment in Series B - Disc Medicine
Novo Holdings
Novo Holdings investment in Series B - Disc Medicine
Key Employee Changes
| Date | New article |
|---|---|
| 2020-01-30 | Disc Medicine Adds Longtime Acceleron Pharma Exec as New CEO |
Official Site Inspections
http://www.discmedicine.com Semrush global rank: 5.5 M Semrush visits lastest month: 1.55 K
- Host name: 197.103.224.35.bc.googleusercontent.com
- IP address: 35.224.103.197
- Location: United States
- Latitude: 38.6583
- Longitude: -77.2481
- Timezone: America/New_York
More informations about "Disc Medicine"
About Us - Disc Medicine
Jean spent 16 years at Genzyme advancing within the organization during its most rapid phase of growth. She spent eight years at Genzyme as the Senior Vice President of Finance for all nine …See details»
Disc Medicine
Disc Medicine is a biopharmaceutical company dedicated to transforming the lives of patients with hematologic disorders.See details»
Disc Medicine - Crunchbase Company Profile & Funding
Disc Medicine achieved a significant milestone by clearing a technical benchmark, attaining an 80-plus Relative Strength (RS) rating. This upgrade in RS rating indicates a positive trend in the company's stock performance.See details»
Disc Medicine - Overview, News & Similar companies - ZoomInfo
Jun 14, 2024 Disc Medicine contact info: Phone number: (617) 674-9274 Website: www.discmedicine.com What does Disc Medicine do? Disc Medicine is a clinical-stage …See details»
Disc Medicine - LinkedIn
Disc Medicine Biotechnology Research Watertown, Massachusetts 3,594 followers Disc Medicine is a biopharmaceutical company dedicated to transforming the lives of patients with hematologic disorders.See details»
Gemini Therapeutics and Disc Medicine Announce Merger …
Aug 10, 2022 About the Proposed Transaction, Management and Organization. Pre-merger Gemini shareholders are expected to own approximately 28% of the combined company and …See details»
Disc Medicine - Bain Capital Life Sciences
Disc Medicine (NASDAQ:IRON) is a clinical-stage biopharmaceutical company committed to discovering, developing, and commercializing novel treatments for patients who suffer from …See details»
Disc Medicine Announces Completion of Merger with Gemini
Dec 29, 2022 The combined company will operate as Disc Medicine and will trade on the Nasdaq Global Market under the ticker symbol “IRON” Approximately $175 million of cash and …See details»
Disc Medicine Announces Completion of Merger with Gemini …
The combined company will operate as Disc Medicine and will trade on the Nasdaq Global Market under the ticker symbol “IRON”Approximately $175 million of cash and cash equivalents to …See details»
Our Science - Disc Medicine
Our R&D strategy focuses on pathways that will have a clear impact on red blood cell development (or erythropoiesis). Our programs are designed to modulate two critical processes required for functional RBCs: heme biosynthesis and iron …See details»
Disc Medicine - Craft
Sep 5, 2024 Disc Medicine develops therapies that restore red blood cell production in hematologic diseases. Its approach focuses on targeting hepcidin, a key regulator of iron …See details»
Disc Medicine - VentureRadar
"Disc Medicine is a clinical-stage biopharmaceutical company committed to discovering, developing, and commercializing novel treatments for patients who suffer from serious …See details»
News Release Details - Disc Medicine Inc.
Dec 20, 2023 We are building a portfolio of innovative, potentially first-in-class therapeutic candidates that aim to address a wide spectrum of hematologic diseases by targeting …See details»
News Release Details - ir.discmedicine.com
Nov 4, 2024 For more information, please visit www.discmedicine.com. Disc Cautionary Statement Regarding Forward-Looking Statements. This press release contains “forward …See details»
Culture & Careers - Disc Medicine
If you suspect any fraudulent activity or misrepresentation in connection with a Disc Medicine job opportunity, please report it to [email protected]. Additionally, you can report any …See details»
Disc Medicine Announces Completion of Merger with Gemini …
News & Events Disc Medicine Announces Completion of Merger with Gemini Therapeutics. The combined company will operate as Disc Medicine and will trade on the Nasdaq Global Market …See details»
Disc Medicine Announces $90 Million Series B Financing to …
Sep 2, 2021 Disc Medicine Announces $90 Million Series B Financing to Advance Portfolio of Clinical-Stage Therapies for Hematologic Diseases -Proceeds will be used to advance multiple …See details»
Disc Medicine to Participate in the Jefferies Global Healthcare ...
WATERTOWN, Mass., May 30, 2024 (GLOBE NEWSWIRE) -- Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the discovery, …See details»
News & Events - discmedicine.com
News & Events Disc Medicine Expands Leadership Team with Appointment of Industry Veteran Steve Caffé, MD as Chief Regulatory Officer. Dr. Steve Caffé is an accomplished industry …See details»
Clinical Trials - Disc Medicine
At this time, we believe that participation in one of our clinical trials is the appropriate way to access our investigational therapies. If you have additional questions, please speak with your …See details»